VNRXNYSEIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
VOLITIONRX LTD
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.17−0.01 (-3.50%)
Close on Oct 19, 2026
- Market cap
- $1.59M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Volitionrx's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Sep 22, 2026 | Sep 25, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 9, 2026 | Sep 15, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 11, 2026 | Sep 14, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 2, 2026 | Sep 2, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 27, 2026 | Sep 2, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 19, 2026 | Aug 24, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 13, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 13, 2026 | Aug 13, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 6, 2026 | Aug 7, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 17, 2026 | Jul 21, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 17, 2026 | Jun 18, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 7, 2026 | Jun 10, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Jul 17, 2026 | Jun 2, 2026 | SEC EDGAR |
| Current report | 8-K | May 21, 2026 | May 22, 2026 | SEC EDGAR |
| Current report | 8-K | May 12, 2026 | May 15, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 14, 2026 | SEC EDGAR |
| Current report | 8-K | May 14, 2026 | May 14, 2026 | SEC EDGAR |
| Annual report, amended | 10-K/A | Dec 31, 2025 | Apr 30, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 28, 2026 | Apr 28, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 23, 2026 | Apr 23, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 17, 2026 | Apr 17, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 31, 2026 | Apr 1, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 31, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 31, 2026 | Mar 31, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 17, 2026 | Feb 20, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Feb 10, 2026 | Feb 11, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 6, 2026 | Feb 9, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 7, 2026 | Jan 8, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 5, 2025 | Dec 11, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 13, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 13, 2025 | Nov 13, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 7, 2025 | Nov 7, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 10, 2025 | Oct 14, 2025 | SEC EDGAR |
| Quarterly report, amended | 10-Q/A | Jun 30, 2025 | Aug 15, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 14, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 14, 2025 | Aug 14, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 1, 2025 | Aug 4, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 18, 2025 | Jun 20, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 15, 2025 | SEC EDGAR |
| Current report | 8-K | May 15, 2025 | May 15, 2025 | SEC EDGAR |